Related Experiment Video
Updated: May 20, 2026
06:10
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer
Inbal Daniel-Meshulam1, Shlomo Ya'akobi, Chen Ankri
1Laboratory of Tumor Immunology and Immunotherapy, The Mina and Everard Goodman Faculty of Life Sciences , Bar-Ilan University, Ramat Gan, Israel.
Frontiers in Immunology
|July 12, 2012
Summary
Genetic modification of T-cells using T-cell receptors (TCRs) offers a promising approach for treating cancer and infectious diseases. Ongoing research focuses on enhancing TCR-gene transfer efficacy for improved clinical outcomes.
Area of Science:
- Immunology
- Gene Therapy
- Oncology
Background:
- T-cells are crucial for immune responses against pathogens and cancer.
- T-cell receptor (TCR) specificity determines their targeting ability.
- Genetic modification of T-cells with specific TCRs is a therapeutic strategy.
Purpose of the Study:
- To review recent advancements in TCR-gene transfer technology.
- To explore the application of TCR-gene modified T-cells in treating various diseases.
- To highlight areas of ongoing research for improving TCR-gene therapy.
Main Methods:
- Survey of recent studies on TCR-gene transfer techniques.
- Analysis of clinical trial data for TCR-gene modified cell therapies.
- Review of research focused on enhancing TCR-gene transfer reliability and efficacy.
Main Results:
- TCR-gene modified T-cells have shown notable clinical responses in cancer patients.
- Significant research is dedicated to optimizing TCR-gene transfer methods.
- The approach holds potential for treating malignant, autoimmune, and infectious diseases.
Conclusions:
- TCR-gene transfer is a powerful tool for engineering T-cells for therapeutic purposes.
- Further research is essential to maximize the clinical benefits of TCR-gene therapy.
- This strategy represents a rapidly evolving field with broad therapeutic applications.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...